Abstract

目的探讨外源性肺表面活性物质治疗重症新生儿肺透明膜病(HMD)的疗效. 方法对重症HMD病儿于生后气管内给药,观察用药后临床表现、血气结果、肺部X线以及并发症的变化. 结果33例中30例给药后即刻症状和体征改善,血气分析结果明显好转;给药3d内肺部X线23例有明显改善;33例中16例存活,其中9例有严重并发症. 结论外源性肺表面活性物质对重症HMD有肯定疗效,在改善氧气交换和肺部病变方面发挥重要作用.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call